about
Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina FasoMeningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from AfricaEvolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso.Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database.Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.Neisseria meningitidis: biology, microbiology, and epidemiology.Improvement of immunogenicity of meningococcal lipooligosaccharide by coformulation with lipidated transferrin-binding protein B in liposomes: implications for vaccine development.Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy.Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.Meningococcal disease: changes in epidemiology and prevention.Field evaluation of rapid diagnostic tests for meningococcal meningitis in Niger.Neisseria meningitidis infection: who, when and where?Serogroup A meningococcal conjugate vaccines in Africa.Use of a new single multiplex PCR-based assay for direct simultaneous characterization of six Neisseria meningitidis serogroups.Neisseria meningitidis Serogroup X ST-5799 (ST-22 complex) in Turkey: A Unique Pediatric Case.Neisseria meningitidis serogroup X sequence type 767 in Turkey.Vaccine Prevention of Meningococcal Disease in Africa: Major Advances, Remaining Challenges.Vaccination strategies for the prevention of meningococcal disease.
P2860
Q28744396-1BBC32C2-B4CD-4BF7-B29B-6CD8DADD8370Q34039044-2C984391-93BB-4A69-9313-A54580D16245Q34363122-36660641-9D1B-4058-B922-10712F3FBC8FQ34428829-0B40479C-4D1A-4D5E-A4D6-41E871F48B72Q34430626-F2BD026E-1496-4235-B859-56DF105CE772Q34632986-E9492276-E406-4508-B531-D62B33DE18CDQ35940728-6BBE27AA-F6C8-4553-8540-38A32D0E8D25Q37461347-808CD91F-1732-4E26-8C59-2BB9E1B34059Q37956384-8E1D79E7-85C1-4A61-8E5B-C93892D54345Q38052545-1A66B1EB-68D4-4075-A1DF-AAE435D136FBQ38424058-DA4BCFFA-03BE-4037-852C-716CD8AF10B1Q38550405-E0B4F56B-B60C-4F28-9F74-0DAC16714626Q38584375-5972FFDA-E92A-49D7-B6E1-9173AB8DE576Q41955345-C836D98D-5839-48DF-ADCE-12BB4C2A44DFQ41995737-BC3E4499-952F-4C1B-A8A5-958F4084E8C6Q42571364-4734A271-F684-4A29-AF22-C4DDF6A3A024Q46535546-17C1B30F-881E-494B-B3F0-60DB6407AAD1Q54964676-668A50C0-E7C7-41D1-9D37-1D9BDA3A5C18
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Serogroup X in meningococcal disease, Western Kenya.
@en
Serogroup X in meningococcal disease, Western Kenya.
@nl
type
label
Serogroup X in meningococcal disease, Western Kenya.
@en
Serogroup X in meningococcal disease, Western Kenya.
@nl
prefLabel
Serogroup X in meningococcal disease, Western Kenya.
@en
Serogroup X in meningococcal disease, Western Kenya.
@nl
P2093
P2860
P356
P1476
Serogroup X in meningococcal disease, Western Kenya.
@en
P2093
Bienvenu Baruani
Dominique A Caugant
Helen S Cox
Sadiki Materu
Thomas Ogaro
P2860
P304
P356
10.3201/EID1306.070042
P577
2007-06-01T00:00:00Z